Israel Englander Inozyme Pharma, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,744,453 shares of INZY stock, worth $4.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,744,453

Previous 1,787,947 2.43%

Holding current value

$4.69 Million

Previous $7.97 Million 14.41%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.31 - $6.0 $187,459 - $260,964	-43,494 Reduced 2.43%	1,744,453 $9.12 Million
Q2 2024 Aug 14, 2024	BUY	$4.33 - $7.31 $4.7 Million - $7.93 Million	1,084,341 Added 154.11%	1,787,947 $7.97 Million
Q1 2024 May 15, 2024	SELL	$4.14 - $7.66 $860,536 - $1.59 Million	-207,859 Reduced 22.8%	703,606 $5.39 Million
Q4 2023 Feb 14, 2024	SELL	$2.71 - $4.5 $3.51 Million - $5.83 Million	-1,294,693 Reduced 58.69%	911,465 $3.88 Million
Q2 2023 Aug 14, 2023	BUY	$4.93 - $6.74 $2.54 Million - $3.47 Million	515,083 Added 30.46%	2,206,158 $12.3 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $5.73 $1.81 Million - $7.98 Million	1,393,139 Added 467.6%	1,691,075 $9.69 Million
Q4 2022 Feb 14, 2023	BUY	$1.05 - $2.82 $134,139 - $360,260	127,752 Added 75.07%	297,936 $313,000
Q3 2022 Nov 14, 2022	SELL	$2.57 - $5.45 $7,473 - $15,848	-2,908 Reduced 1.68%	170,184 $456,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.96 $553,894 - $1.03 Million	173,092 New	173,092 $826,000
Q1 2022 May 16, 2022	SELL	$3.87 - $7.55 $77,214 - $150,637	-19,952 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.58 - $11.5 $49,595 - $102,212	8,888 Added 80.33%	19,952 $136,000
Q3 2021 Nov 15, 2021	SELL	$11.12 - $19.4 $558,768 - $974,830	-50,249 Reduced 81.95%	11,064 $128,000
Q2 2021 Aug 16, 2021	SELL	$15.19 - $21.2 $1.34 Million - $1.86 Million	-87,892 Reduced 58.91%	61,313 $1.05 Million
Q1 2021 May 17, 2021	BUY	$17.77 - $27.9 $2.65 Million - $4.16 Million	149,205 New	149,205 $2.95 Million
Q4 2020 Feb 16, 2021	SELL	$19.95 - $27.55 $801,271 - $1.11 Million	-40,164 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.54 - $30.2 $704,476 - $1.21 Million	40,164 New	40,164 $1.06 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

53M

Call Options Held

3.7K

Put Options Held

5.8K

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $108M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account